Press Releases
Post a press release | Manage press releases
-
Kairos Meridian Launches An Independent, Shorter Path From Problem to Impact
Press release from Kairos Meridian LLC • June 30, 2026 -
OTR3 announces positive phase 2 results in ischemic stroke
Press release from OTR3 • June 30, 2026 -
6 of 12 Top-Selling Glutathione Supplements on Amazon Fail Label Claims in Independent Testing, Cata-Kor Finds
Press release from Cata-Kor • June 26, 2026 -
Woven Health Collective Introduces MARIO to Accelerate Digital Delivery and Strengthen Client Collaboration
Press release from Woven Health Collective • June 26, 2026 -
Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and Autoimmune Disease
Press release from Immunai • June 25, 2026 -
QED Science Launches AI Infrastructure for Scientific Validation
Press release from QED Science • June 24, 2026 -
The Next Bottleneck in AI Drug Discovery Isn't Molecule Design. It's Analytical Validation. Expert Intelligence Launches EI Signal at BIO 2026.
Press release from Tools for AI, Inc dba Expert Intelligence • June 22, 2026 -
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery.
Press release from Greenstone Biosciences Inc • June 19, 2026 -
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Press release from TrialAssure • June 18, 2026 -
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
Press release from Uniphar • June 17, 2026 -
Cresset releases Flare V12 to cut synthesis and testing cycles with faster, more flexible FEP
Press release from Cresset • June 16, 2026 -
Receptor.AI and onepot Partner to Shorten the Path from Virtual Hits to Assay-Ready Compounds
Press release from Receptor.AI • June 15, 2026 -
Protai Introduces AIMS-Fold Establishing Structural-Proteomics-Guided AI for Induced Proximity Drug Design
Press release from Protai • June 10, 2026 -
Boston Startup nvisualAI Debuts RFID Solution to Automate Lab Inventory with Real-Time Tracking
Press release from nvisualAI • June 10, 2026 -
Trait Biosciences Reports Exploratory Observational Findings from Water-Soluble Cannabidiol (CBD) Formulation in Companion Animals
Press release from Trait Biosciences • June 9, 2026 -
Kivo and CRISPR Therapeutics to Present 52-Day QMS Modernization at DIA 2026 in Philadelphia
Press release from Kivo • June 9, 2026 -
Neovia Oncology Announces Completion of Phase I(a) Study of NEV-801, a Novel Dual Topoisomerase Drug-Drug Conjugate
Press release from Neovia Oncology • June 6, 2026 -
Almac Diagnostic Services Expand NGS Capabilities for Clinical Trial Research
Press release from Almac Group • June 2, 2026 -
Rayca Precision and ASAKE Partner on AI-Designed Therapeutics for Rare and Metabolic Diseases
Press release from Rayca Precision • June 2, 2026 -
Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partnership to Expand Patient Access to Early-Phase Cancer Trials
Press release from The START Center for Cancer Research • May 28, 2026
